수두증 션트 시장 보고서 : 유형별, 제품 유형별, 연령층별, 최종사용자별, 지역별(2024-2032년)

The global hydrocephalus shunts market size reached US$ 450.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 623.8 Million by 2032, exhibiting a growth rate (CAGR) of 3.6% during 2024-2032.

Hydrocephalus shunts refer to a medical device used for treating a condition that occurs when fluid builds up in the brain and results in increased intracranial pressure within the skull. It is commonly available in valves, catheters, adjustable pressure valves and fixed pressure valve variants. It is a flexible tube placed into the brain area where cerebrospinal fluid (CSF) is produced. Hydrocephalus shunts consist of an inflow or proximal catheter that drains CSF from the lateral ventricles, a valve mechanism that regulates intracranial pressure by controlling fluid flow and an outflow or distal catheter that runs under the skin and directs CSF. It assists in soothing the tension on the cerebrum and returning the brain's enlarged ventricles to their actual size.

Hydrocephalus Shunts Market Trends:

The increasing prevalence of brain and neurological disorders among the masses is one of the key factors driving the growth of the market. Hydrocephalus shunts are widely used due to the rising incidence of congenital abnormalities, brain and nerve injuries, accidents leading to central nervous system (CNS) defects and lifestyle diseases. Additionally, the increasing product demand to treat hydrocephalus among infants that could lead to enlargement of the head and damaging brain is favoring the market growth. Moreover, various technological advancements, such as the development of anti-siphon devices that assist in avoiding siphon effects over cerebrospinal fluid, are providing a thrust to the market growth. In line with this, the development of programmable valves for controlling the flow of cerebrospinal fluid and preventing it from moving in the wrong direction is positively impacting the market growth. Other factors, including significant growth in the healthcare industry, along with the implementation of various government initiatives to spread awareness regarding hydrocephalus shunts, are anticipated to drive the market toward growth further across the globe.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global hydrocephalus shunts market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, product type, age group and end user.

Breakup by Type:

Ventriculo-Peritoneal

Ventriculo-Atrial

Ventriculo-Pleural

Lumbo-Peritoneal

Breakup by Product Type:

Hydrocephalus Valves

Adjustable Pressure Valves

Fix Pressure Valves

Hydrocephalus Catheters

Breakup by Age Group:

Infants

Children

Adults

Breakup by End User:

Hospitals

Ambulatory Surgical Centers

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Argi Group, B. Braun Melsungen AG, Christoph Miethke GmbH & Co. KG, G. Surgiwear Ltd., HLL Lifecare Limited, Integra LifeSciences, Kaneka Medix Corporation (Kaneka Corporation), Medtronic Plc, Natus Medical Incorporated, Sophysa, Spiegelberg GmbH & Co. KG (SHS Medizintechnik Holding GmbH) and TKB Corporation.

Key Questions Answered in This Report

• 1. What was the size of the global hydrocephalus shunts market in 2023?
• 2. What is the expected growth rate of the global hydrocephalus shunts market during 2024-2032?
• 3. What has been the impact of COVID-19 on the global hydrocephalus shunts market?
• 4. What are the key factors driving the global hydrocephalus shunts market?
• 5. What is the breakup of the global hydrocephalus shunts market based on the type?
• 6. What is the breakup of the global hydrocephalus shunts market based on the product type?
• 7. What is the breakup of the global hydrocephalus shunts market based on the age group?
• 8. What is the breakup of the global hydrocephalus shunts market based on the end user?
• 9. What are the key regions in the global hydrocephalus shunts market?
• 10. Who are the key players/companies in the global hydrocephalus shunts market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Hydrocephalus Shunts Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Ventriculo-Peritoneal
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Ventriculo-Atrial
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Ventriculo-Pleural
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Lumbo-Peritoneal
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Product Type

• 7.1 Hydrocephalus Valves
  • 7.1.1 Market Trends
  • 7.1.2 Key Segments
    • 7.1.2.1 Adjustable Pressure Valves
    • 7.1.2.2 Fix Pressure Valves
  • 7.1.3 Market Forecast
• 7.2 Hydrocephalus Catheters
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Age Group

• 8.1 Infants
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Children
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Adults
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by End User

• 9.1 Hospitals
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Ambulatory Surgical Centers
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Argi Group
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
  • 15.3.2 B. Braun Melsungen AG
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
    • 15.3.2.3 SWOT Analysis
  • 15.3.3 Christoph Miethke GmbH & Co. KG
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
  • 15.3.4 G. Surgiwear Ltd.
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
  • 15.3.5 HLL Lifecare Limited
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
  • 15.3.6 Integra LifeSciences
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
    • 15.3.6.3 Financials
    • 15.3.6.4 SWOT Analysis
  • 15.3.7 Kaneka Medix Corporation (Kaneka Corporation)
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
  • 15.3.8 Medtronic Plc
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
    • 15.3.8.4 SWOT Analysis
  • 15.3.9 Natus Medical Incorporated
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
    • 15.3.9.4 SWOT Analysis
  • 15.3.10 Sophysa
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
  • 15.3.11 Spiegelberg GmbH & Co. KG (SHS Medizintechnik Holding GmbH)
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
  • 15.3.12 TKB Corporation
    • 15.3.12.1 Company Overview
    • 15.3.12.2 Product Portfolio